Reneo Pharmaceuticals – Addressing The Unmet Need of Rare Genetic Mitochondrial Disease
Gregory Flesher is President and CEO of Reneo Pharmaceuticals, a clinical-stage pharmaceutical company tackling the significant unmet need of developing...
5346 articles
Gregory Flesher is President and CEO of Reneo Pharmaceuticals, a clinical-stage pharmaceutical company tackling the significant unmet need of developing...
Sebastian Seiguer, CEO of Scene Health, formerly emocha Health, and Dr. Learn more on Health Professional Radio.
Nick Nieslanik, Chief Technology Officer at Cleerly, the company creating a new standard of care for heart disease, discusses Cleerly Proxy.
Tram Tran, Chief Medical Officer of Glympse Bio, is developing biosensor technology that is able to measure protease activity from a blood sample to det...
Caring Cross is a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and ensuring access to cures for all patients, ev...
QIAGEN's VP and Head of PCR Business, Michael Scheffler, discusses the QIAcuity system and how it helps biopharma customers with drug discovery and deve...
Ginger Polich, MD, Physical Medicine and Rehabilitation at Massachusetts General Hospital, Brigham discusses new research recently presented at the Amer...
Millennials often prioritize living their “best” lives by ignoring symptoms or postponing a doctor visit – which is easy to do around the busy hol...
Tamara Tobias, ARNP, WHNP-BC, Women’s Health Care Nurse Practitioner & Manager at Seattle Reproductive Medicine discusses FertilityWise, a free, on-de...
Allen Davidoff, PhD, CEO of XORTX Therapeutics, a clinical-stage biotechnology company developing promising therapeutics for progressive kidney disease,...